Showing 7071-7080 of 10619 results for "".
- Breakthrough in HIV: Combination Therapy and Long-term Controlhttps://reachmd.com/news/hiv-combination-therapy-long-term-control/2484687/A UCSF study reports that a combination immunotherapy approach enabled 7 of 10 participants to maintain low-level HIV viremia for several months after stopping antiretroviral therapy,
- Progress in Endobiliary RFA for Cholangiocarcinoma: A Review of Current Evidence and Techniqueshttps://reachmd.com/news/progress-in-endobiliary-rfa-for-cholangiocarcinoma-a-review-of-current-evidence-and-techniques/2484644/Endobiliary radiofrequency ablation (RFA) added to biliary stenting may extend stent patency and palliate symptoms in unresectable extrahepatic cholangiocarcinoma, though study results are heterogeneous. Does RFA plus stenting improve stent patency and survival versu
- Nutritional Interventions Impact on Maternal and Childhood Anemia in Sindh, Pakistanhttps://reachmd.com/news/nutritional-interventions-impact-on-maternal-and-childhood-anemia-in-sindh-pakistan/2484643/Lady Health Worker (LHW)–led community delivery of a wheat–soya blend plus targeted lipid-based or micronutrient powders produced a large program-level decline in maternal anemia, with immediate implications for prenatal and postpartum care. The finding also highlights persistent co
- Lupus-like Skin Disease in MDS/CMML Linked to Clonal Inflammation: Studyhttps://reachmd.com/news/lupuslike-skin-disease-in-mdscmml-linked-to-clonal-inflammation/2484592/Lupus-like manifestations in patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML) appear to represent a distinct clinical entity driven by clonal hematopoiesis rather than classic autoimmunity, according to a new case-control study
- 2025 ASH Advocacy Awards: Honoring Excellence in Hematology Advocacyhttps://reachmd.com/news/2025-ash-advocacy-awards-honoring-excellence-in-hematology-advocacy/2484616/The 2025 ASH Advocacy Awards recognized bipartisan legislators and patient organizat
- Advancements in Predicting Postoperative Reintubation Riskhttps://reachmd.com/news/advancements-in-predicting-postoperative-reintubation-risk/2484639/A new point-based risk score identifies patients at elevated risk of reintubation within 24 hours and reduces unrecognized events—its discrimination (AUROC 0.831) supports targeted postoperative and ED surveillance. Age <1 or >65 years, ASA classification ≥III,
- Phase II DAHLIAS Trial: Nipocalimab's Impact on Sjögren Diseasehttps://reachmd.com/news/phase-ii-dahlias-trial-nipocalimabs-impact-on-sjogren-disease/2484633/The DAHLIAS trial notes clinically meaningful reductions in disease activity with nipocalimab and supports FcRn blockade as the mechanistic rationale for antibody lowering. The authors
- Understanding Self-Harm and Suicidality in Autistic Adults Across the Lifespanhttps://reachmd.com/news/understanding-self-harm-and-suicidality-in-autistic-adults-across-the-lifespan/2484630/New population-level data show higher rates of self-harm and suicidality among autistic adults, most pronounced in midlife and older age. This trend matters for adult mental
- RVL Pharmaceuticals Announces New CEO, Chief Growth Officerhttps://reachmd.com/news/rvl-pharmaceuticals-announces-new-ceo-chief-growth-officer/2484615/RVL Pharmaceuticals, Inc. has appointed Lori Deo as Chief Executive Officer and Amy Shah as Chief Growth Officer, signaling a strategic leadership shift aimed at accelerating growth for its lead product, Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1%. Deo, who previously se
- AI Model Accurately Scores Psoriasis Severity from Clinical Imageshttps://reachmd.com/news/ai-model-accurately-scores-psoriasis-severity-from-clinical-images/2484588/A new study demonstrates the potential of artificial intelligence (AI) to improve the consistency and objectivity of psoriasis severity assessments based on 2D clinical images. Researchers for the study used the YOLOv8 deep lear